Literature DB >> 21355865

HLA-C as a mediator of natural killer and T-cell activation: spectator or key player?

Marie-Eve Blais1, Tao Dong, Sarah Rowland-Jones.   

Abstract

The biochemical properties of the HLA-C antigen differ substantially from those of HLA-A and -B molecules. For this reason, HLA-C diversity and expression at the cell surface are much lower than its counterparts and in consequence HLA-C-restricted responses have been infrequently detected and described. In this review we summarise the key differences between HLA-C and other class I molecules and provide an update on natural killer and T-cell responses restricted by HLA-C. We also discuss the different clinical settings associated with HLA-C alleles which mainly consist of autoimmune disorders, cancers and chronic infections.
© 2011 The Authors. Immunology © 2011 Blackwell Publishing Ltd.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21355865      PMCID： PMC3088962          DOI： 10.1111/j.1365-2567.2011.03422.x

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


  48 in total

1.  The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells.

Authors:  G B Cohen; R T Gandhi; D M Davis; O Mandelboim; B K Chen; J L Strominger; D Baltimore
Journal:  Immunity       Date:  1999-06       Impact factor: 31.745

2.  Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand.

Authors:  J C Boyington; S A Motyka; P Schuck; A G Brooks; P D Sun
Journal:  Nature       Date:  2000-06-01       Impact factor: 49.962

3.  Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex.

Authors:  Q R Fan; E O Long; D C Wiley
Journal:  Nat Immunol       Date:  2001-05       Impact factor: 25.606

4.  A single bottleneck in HLA-C assembly.

Authors:  Leonardo Sibilio; Aline Martayan; Andrea Setini; Elisa Lo Monaco; Elisa Tremante; Richard H Butler; Patrizio Giacomini
Journal:  J Biol Chem       Date:  2007-10-23       Impact factor: 5.157

5.  Sequence-based typing provides a new look at HLA-C diversity.

Authors:  S Turner; M E Ellexson; H D Hickman; D A Sidebottom; M Fernández-Viña; D L Confer; W H Hildebrand
Journal:  J Immunol       Date:  1998-08-01       Impact factor: 5.422

6.  Potential underestimation of HLA-C-restricted cytotoxic T-lymphocyte responses.

Authors:  P J Goulder; M Bunce; G Luzzi; R E Phillips; A J McMichael
Journal:  AIDS       Date:  1997-12       Impact factor: 4.177

7.  Nef interference with HIV-1-specific CTL antiviral activity is epitope specific.

Authors:  Sama Adnan; Arumugam Balamurugan; Alicja Trocha; Michael S Bennett; Hwee L Ng; Ayub Ali; Christian Brander; Otto O Yang
Journal:  Blood       Date:  2006-08-01       Impact factor: 22.113

8.  HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes.

Authors:  K L Collins; B K Chen; S A Kalams; B D Walker; D Baltimore
Journal:  Nature       Date:  1998-01-22       Impact factor: 49.962

9.  Novel cytotoxic T-lymphocyte escape mutation by a three-amino-acid insertion in the human immunodeficiency virus type 1 p6Pol and p6Gag late domain associated with drug resistance.

Authors:  Jianhong Cao; John McNevin; Matthew McSweyn; Yi Liu; James I Mullins; M Juliana McElrath
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

10.  A whole-genome association study of major determinants for host control of HIV-1.

Authors:  Jacques Fellay; Kevin V Shianna; Dongliang Ge; Sara Colombo; Bruno Ledergerber; Mike Weale; Kunlin Zhang; Curtis Gumbs; Antonella Castagna; Andrea Cossarizza; Alessandro Cozzi-Lepri; Andrea De Luca; Philippa Easterbrook; Patrick Francioli; Simon Mallal; Javier Martinez-Picado; José M Miro; Niels Obel; Jason P Smith; Josiane Wyniger; Patrick Descombes; Stylianos E Antonarakis; Norman L Letvin; Andrew J McMichael; Barton F Haynes; Amalio Telenti; David B Goldstein
Journal:  Science       Date:  2007-07-19       Impact factor: 47.728
View more
  43 in total

1.  Correlation of Single Nucleotide Polymorphism 35-Kb Upstream of HLA-C and Clinical Profile of Multidrug-Resistant Tuberculosis.

Authors:  Umi Hani' Vismayanti Lismana; Afiono Agung Prasetyo
Journal:  J Clin Diagn Res       Date:  2015-09-01

2.  High frequency of HIV mutations associated with HLA-C suggests enhanced HLA-C-restricted CTL selective pressure associated with an AIDS-protective polymorphism.

Authors:  Marie-Eve Blais; Yonghong Zhang; Tim Rostron; Harry Griffin; Stephen Taylor; Keyi Xu; Huiping Yan; Hao Wu; Ian James; Mina John; Tao Dong; Sarah L Rowland-Jones
Journal:  J Immunol       Date:  2012-04-02       Impact factor: 5.422

Review 3.  Endoplasmic Reticulum Aminopeptidase 2, a common immunological link to adverse pregnancy outcomes and cancer clearance?

Authors:  Eun D Lee
Journal:  Placenta       Date:  2017-03-18       Impact factor: 3.481

4.  Recipient HLA-C Haplotypes and microRNA 148a/b Binding Sites Have No Impact on Allogeneic Hematopoietic Cell Transplantation Outcomes.

Authors:  Gretchen A Hoff; Johannes C Fischer; Katharine Hsu; Sarah Cooley; Jeffrey S Miller; Tao Wang; Michael Haagenson; Stephen Spellman; Stephanie J Lee; Markus Uhrberg; Jeffrey M Venstrom; Michael R Verneris
Journal:  Biol Blood Marrow Transplant       Date:  2016-10-13       Impact factor: 5.742

5.  Immunogenomic correlates of response to cetuximab monotherapy in head and neck squamous cell carcinoma.

Authors:  Daniel L Faden; Fernando Concha-Benavente; Anish B Chakka; Elizabeth L McMichael; Uma Chandran; Robert L Ferris
Journal:  Head Neck       Date:  2019-03-04       Impact factor: 3.147

Review 6.  The emerging role of HLA-C in HIV-1 infection.

Authors:  Deanna A Kulpa; Kathleen L Collins
Journal:  Immunology       Date:  2011-10       Impact factor: 7.397

7.  The molecular basis for peptide repertoire selection in the human leucocyte antigen (HLA) C*06:02 molecule.

Authors:  Jesse I Mobbs; Patricia T Illing; Nadine L Dudek; Andrew G Brooks; Daniel G Baker; Anthony W Purcell; Jamie Rossjohn; Julian P Vivian
Journal:  J Biol Chem       Date:  2017-08-30       Impact factor: 5.157

8.  Immunoprevalence and immunodominance of HLA-Cw*0801-restricted T cell response targeting the hepatitis B virus envelope transmembrane region.

Authors:  Anthony T Tan; Pimpayao Sodsai; Adeline Chia; Eglantine Moreau; Melissa H Y Chng; Christine Y L Tham; Zi Zong Ho; Nasirah Banu; Nattiya Hirankarn; Antonio Bertoletti
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

9.  Decidual T Cells Exhibit a Highly Differentiated Phenotype and Demonstrate Potential Fetal Specificity and a Strong Transcriptional Response to IFN.

Authors:  Richard M Powell; David Lissauer; Jennifer Tamblyn; Andrew Beggs; Philip Cox; Paul Moss; Mark D Kilby
Journal:  J Immunol       Date:  2017-10-06       Impact factor: 5.422

10.  An Immunoinformatics Approach for SARS-CoV-2 in Latam Populations and Multi-Epitope Vaccine Candidate Directed towards the World's Population.

Authors:  Andrés Felipe Cuspoca; Laura Lorena Díaz; Alvaro Fernando Acosta; Marcela Katherine Peñaloza; Yardany Rafael Méndez; Diana Carolina Clavijo; Juvenal Yosa Reyes
Journal:  Vaccines (Basel)       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.